@article{71dbbad5135141d0ba451dd171aee4e9,
title = "Glycosylation of immunoglobulin light chains is highly prevalent in cold agglutinin disease",
author = "Surbhi Sidana and Murray, \{David L.\} and Surendra Dasari and Go, \{Ronald S.\} and Eli Muchtar and Willrich, \{Maria A.\} and Melissa Snyder and Mindy Kohlhagen and Lust, \{John A.\} and Kourelis, \{Taxiarchis V.\} and Kumar, \{Shaji K.\} and Angela Dispenzieri and Gertz, \{Morie A.\}",
note = "Funding Information: S.S.: Consultancy: Janssen; D.L.M.: Intellectual property rights on Mass‐Fix assay; S.D.: Intellectual property rights on Mass‐Fix assay. A.D.: Research Funding from Celgene, Takeda, Prothena, Jannsen, Pfizer, Alnylam, G.S.K.; S.K.K.: Research Funding and membership on an entity's Board of Directors or advisory committees: AbbVie, Celgene, Janssen, KITE, Merck. Membership on an entity's Board of Directors or advisory committees: Oncopeptides, Takeda. Research funding from Novartis and Roche.; M.A.G.: Honoraria/consultancy from Ionis, Alnylam, Prothena, Celgene, Janssen, Specytrum, Annexon, Apellis, Amgen, Medscape, Abbvie, Research to Practice, Physcians Education Resource and Teva. ",
year = "2020",
month = sep,
day = "1",
doi = "10.1002/ajh.25843",
language = "English (US)",
volume = "95",
pages = "E222--E225",
journal = "American journal of hematology",
issn = "0361-8609",
publisher = "John Wiley and Sons Inc.",
number = "9",
}